Shattuck Labs, Inc. announced that it has entered into a securities purchase agreement to issue 3,100,823 pre-funded warrants to purchase 3,100,823 shares of common stock at an issue price of $6.4499 per pre-funded warrant for gross proceeds of $19,999,998 on December 21, 2023. The transaction is expected to close on December 26, 2023.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.15 USD | +1.85% | -4.88% | -1.54% |
02:31pm | Shattuck Labs Says FDA Grants Orphan Drug Designation to Leukemia Drug; Shares Rise | MT |
02:20pm | Shattuck Labs Gets FDA's Orphan Drug Status for Leukemia Treatment | DJ |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.54% | 334M | |
+51.85% | 57.87B | |
+41.05% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |
- Stock Market
- Equities
- STTK Stock
- News Shattuck Labs, Inc.
- Shattuck Labs, Inc. announced that it expects to receive $19.999998 million in funding